Related Experiment Video
Updated: Aug 19, 2026

Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis
Published on: July 8, 2025
Risk factors for pressure alopecia after pyeloplasty in children
Yang Zhao1, Xiaowei Zhang1,2, Xiaoli Shen1
1Senior Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Insights
Prolonged head compression and lack of repositioning during pediatric pyeloplasty increase the risk of pressure alopecia (PA). Limiting head compression to under 3.5 hours can help prevent PA in children.
Area of Science:
- Pediatric Urology
- Surgical Complications
- Alopecia Research
Background:
- Minimally invasive pyeloplasty is a common procedure for pediatric hydronephrosis.
- Postoperative pressure alopecia (PA) is a recognized complication following such procedures.
- Understanding risk factors is crucial for preventing PA in pediatric patients.
Purpose of the Study:
- To identify risk factors associated with pressure alopecia (PA) after pediatric pyeloplasty.
- To propose preventive strategies for PA in children undergoing pyeloplasty.
Main Methods:
- Retrospective analysis of 288 pediatric patients undergoing minimally invasive pyeloplasty.
- Comparison of demographics, head compression duration, and intraoperative positioning between patients with and without PA.
- Multivariate logistic regression and ROC curve analysis to identify independent risk factors and predictive values.
Main Results:
- 22 out of 288 children (7.64%) developed postoperative PA.
- Lack of intraoperative head repositioning (OR=6.00) and prolonged head compression (OR=2.90) were independent risk factors for PA.
- Head compression duration >3.5 hours was identified as a significant predictor of PA with 86.8% sensitivity.
Conclusions:
- Absence of regular intraoperative head repositioning and prolonged head compression are key risk factors for PA post-pediatric pyeloplasty.
- Head compression exceeding 3.5 hours significantly elevates the risk of developing PA.
- Strengthening intraoperative head positioning management and implementing targeted protective measures are recommended to prevent PA.
Objective:
To explore the risk factors for pressure alopecia (PA) after pyeloplasty in children and propose preventive measures.
Methods:
A retrospective analysis was conducted on pediatric patients with hydronephrosis who underwent minimally invasive pyeloplasty (laparoscopic or robot-assisted laparoscopic) between October 2018 and October 2020. General demographics, head compression duration, intraoperative head positioning management and scalp protective measures were compared between patients with and without postoperative PA. Variables with significant differences in univariate analysis were included in multivariate Logistic regression. The receiver operating characteristic (ROC) curve was used to assess the predictive value of head compression duration for PA.
Results:
A total of 288 children were enrolled, among whom 22 (7.64%) developed postoperative PA. Multivariate Logistic regression revealed that lack of intraoperative head repositioning (OR = 6.00, 95% CI: 1.91-23.96, P = 0.005) and prolonged head compression duration (OR = 2.90, 95% CI: 1.81-4.79, P < 0.001) were independent risk factors for PA. ROC analysis showed the area under the curve (AUC) was 0.823 (95% CI: 0.731-0.915). The optimal cut-off value of head compression duration was 3.5 h, with a sensitivity of 86.8% and a specificity of 72.7%.
Conclusion:
Absence of regular intraoperative head repositioning and prolonged head compression duration are independent risk factors for PA after pediatric pyeloplasty. A head compression duration longer than 3.5 h markedly increases PA risk. Intraoperative position management should be strengthened and targeted protective measures should be implemented.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Pyelonephritis I: Introduction
Kidney Transplant III: Nursing Management
Increased Intracranial Pressure l: Introduction
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications